Search
Searching Content indexed under Intellectual Property by Phillip Bradley ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Once Again, Retained Rights In Federally Funded, Patented Drugs Will Not Be Asserted To Control Price
In a June 7, 2016, letter to Rep. Lloyd Doggett (D-TX), Secretary of Health and Human Services Sylvia Burwell again reaffirmed the agency's position that the exercise of march-in rights with respect to Xtandi was not appropriate.
United States
6 Jul 2016
2
What You Need To Know About Retained Rights In Federally Funded Patented Drugs
More than 50 members of Congress, led by Rep. Lloyd Doggett (D-TX), sent a letter to Secretary of Health and Human Services Sylvia Matthews Burwell and to National Institutes of Health (NIH) Director Francis Collins on January 11, 2016, urging the agencies "to utilize your existing statutory authority to respond to the soaring cost of pharmaceuticals" to address "price gouging" by pharmaceutical manufacturers
United States
1 Apr 2016
Links to Result pages
 
1